We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $767M
1-Year Est. Return 119.71%
This Fund
S&P 500
This Quarter Est. Return
+2.31%
1 Year Est. Return
+119.71%
3 Year Est. Return
+244.81%
5 Year Est. Return
+382.5%
10 Year Est. Return
+2,655.81%
AUM
$720M
AUM Growth
-$214M
Cap. Flow
+$56.8M
Cap. Flow %
7.89%
Top 10 Hldgs %
53.82%
Holding
93
New
36
Increased
15
Reduced
13
Closed
19

Top Buys

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$16.4M
2
BIIB icon
Biogen
BIIB
+$11.8M
3
ADBE icon
Adobe
ADBE
+$11M
4
PANW icon
Palo Alto Networks
PANW
+$10.9M
5
KRNT icon
Kornit Digital
KRNT
+$9.29M

Top Sells

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$32.5M
2
FIVN icon
FIVE9
FIVN
+$12.8M
3
ALT icon
Altimmune
ALT
+$11.7M
4
NICE icon
Nice
NICE
+$10.9M
5
JNJ icon
Johnson & Johnson
JNJ
+$10.2M

Sector Composition

Rank Sector Weight
1 Healthcare 66.85%
2 Miscellaneous 22.37%
3 Technology 7.17%
4 Industrials 1.24%
5 Consumer Discretionary 1.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QQQ icon
1
PUT
Invesco QQQ Trust
QQQ
$482B
$87M 12.07%
+325,500
New +$98.2M
AZN icon
2
AstraZeneca
AZN
$257B
$49.2M 6.83%
448,530
+49,225
+12% +$6.24M
LLY icon
3
Eli Lilly
LLY
$1.02T
$46.4M 6.44%
143,550
+11,300
+9% +$3.58M
SNY icon
4
Sanofi
SNY
$103B
$46.2M 6.41%
1,214,515
+368,300
+44% +$16.4M
JNJ icon
5
Johnson & Johnson
JNJ
$646B
$35.3M 4.9%
216,151
-60,300
-22% -$10.2M
MRK icon
6
Merck
MRK
$362B
$31.6M 4.39%
367,000
+82,000
+29% +$7.32M
NVO
7
Novo Nordisk
NVO
$191B
$29.5M 4.1%
592,880
+70,000
+13% +$3.75M
ABBV icon
8
AbbVie
ABBV
$463B
$21.8M 3.02%
162,285
-56,100
-26% -$8.05M
NVDA icon
9
CALL
NVIDIA
NVDA
$5.29T
$21M 2.91%
+1,726,000
New +$27.3M
SNDX icon
10
Syndax Pharmaceuticals
SNDX
$1.59B
$19.8M 2.74%
822,696
-316,633
-28% -$7.1M
TEVA icon
11
CALL
Teva Pharmaceutical Industries Limited
TEVA
$45.8B
$17.8M 2.48%
2,210,000
-1,171,600
-35% -$10.4M
BIIB icon
12
Biogen
BIIB
$32.2B
$14.8M 2.06%
+55,500
New +$11.8M
CRNX
13
DELISTED
Crinetics Pharmaceuticals
CRNX
$12.3M 1.71%
626,552
+39,732
+7% +$810K
U icon
14
CALL
Unity
U
$18.6B
$11.7M 1.63%
+367,500
New +$15.1M
KURA icon
15
Kura Oncology
KURA
$1.05B
$10.8M 1.5%
789,952
+295,357
+60% +$4.56M
KZR
16
DELISTED
Kezar Life Sciences
KZR
$10.7M 1.49%
124,581
+94,616
+316% +$9.19M
KDNY
17
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$10.5M 1.46%
534,358
-109,373
-17% -$2.19M
ISEE
18
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$10.4M 1.45%
581,829
-380,641
-40% -$5M
PANW icon
19
Palo Alto Networks
PANW
$306B
$10.3M 1.43%
+126,000
New +$10.9M
WIX icon
20
WIX.com
WIX
$3.38B
$10.1M 1.4%
+129,000
New +$8.89M
SWTX
21
DELISTED
SpringWorks Therapeutics
SWTX
$8.61M 1.19%
301,625
-235,039
-44% -$6.74M
KRNT icon
22
Kornit Digital
KRNT
$667M
$8.59M 1.19%
+322,926
New +$9.29M
GLBE icon
23
Global E Online
GLBE
$6.33B
$8.34M 1.16%
+311,460
New +$8.87M
PNT
24
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$8.14M 1.13%
+1,052,842
New +$8.94M
ADBE icon
25
Adobe
ADBE
$99.6B
$8.02M 1.11%
+29,150
New +$11M
1
2 3 4

Similar funds

ISWM
Independent Solutions Wealth Management Williamsville, New York $766M AUM 31.53% 1-Year Est. Return
ACP
Albar Capital Partners London, United Kingdom $767M AUM 61.96% 1-Year Est. Return
NIM
Nexus Investment Management Toronto, Ontario, Canada $767M AUM 30.97% 1-Year Est. Return
ACM
Arvin Capital Management Austin, Texas $766M AUM 36.51% 1-Year Est. Return
CBT
Crews Bank & Trust Wauchula, Florida $766M AUM 19.5% 1-Year Est. Return
SPIA
Strategic Point Investment Advisors Providence, Rhode Island $767M AUM 17.58% 1-Year Est. Return
CNB
Camden National Bank Camden, Maine $767M AUM 14.32% 1-Year Est. Return
HI
Hendershot Investments Centreville, Virginia $766M AUM 10.81% 1-Year Est. Return

Sphera Funds Management's Q3 2022 Portfolio in Review

As of Q3 2022, Sphera Funds Management held 93 positions worth $720M, down 23% from $935M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Sphera Funds Management deployed $56.8M of net new capital in Q3 2022, opening 36 new positions and adding to 15 existing holdings. Its largest new stake was Biogen: 55,500 shares worth $14.8M.

By sector, the portfolio is most concentrated in Healthcare at 67% of assets, up from 48% a quarter earlier, followed by Miscellaneous and Technology.

On the sell side, the largest reduction was Altimmune, an estimated $11.7M trimmed.

  • Sphera Funds Management's largest Q3 2022 buy was Biogen: 55,500 shares worth $14.8M.
  • Sphera Funds Management added most to Sanofi in Q3 2022, an estimated $16.4M increase.
  • Sphera Funds Management's biggest Q3 2022 reduction was Altimmune, cutting an estimated $11.7M.
  • Sphera Funds Management fully exited State Street SPDR S&P Biotech ETF in Q3 2022, selling an estimated $32.5M.
  • Sphera Funds Management's ten largest holdings make up 54% of its $720M portfolio in Q3 2022.
  • Sphera Funds Management opened 36 new positions and closed 19 in Q3 2022.
  • Sphera Funds Management's portfolio value fell 23% quarter-over-quarter to $720M.

Based on Sphera Funds Management's 13F filing for Q3 2022, filed 14 Nov 2022.